Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126540332 | 12654033 | 2 | F | 20160714 | 20160817 | 20160816 | 20160831 | EXP | LM20160752/LM1600768 | FR-ZYDUS-011925 | ZYDUS PHARM | 65.00 | YR | M | Y | 0.00000 | 20160831 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126540332 | 12654033 | 1 | PS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | UNKNOWN | 201686 | |||||||||||
| 126540332 | 12654033 | 2 | SS | TRAMADOL. | TRAMADOL | 1 | Oral | 400 MG (200 MG,2 IN 1 D) | UNKNOWN | 90404 | 400 | MG | BID | ||||||
| 126540332 | 12654033 | 3 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG (40 MG,1 IN 1 D) | UNKNOWN | 0 | 40 | MG | QD | ||||||
| 126540332 | 12654033 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG (20 MG,1 IN 1 D) | N | UNKNOWN | 0 | 20 | MG | QD | |||||
| 126540332 | 12654033 | 5 | SS | ESTAZOLAM. | ESTAZOLAM | 1 | Oral | 2 MG (2 MG,1 IN 1 D) | UNKNOWN | 0 | 2 | MG | QD | ||||||
| 126540332 | 12654033 | 6 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Oral | 10 MG (10 MG,1 IN 1 D) | UNKNOWN | 0 | 10 | MG | QD | ||||||
| 126540332 | 12654033 | 7 | SS | DIAZEPAM. | DIAZEPAM | 1 | Oral | 5 MG (5 MG,1 IN 1 D) | UNKNOWN | 0 | 5 | MG | QD | ||||||
| 126540332 | 12654033 | 8 | SS | SILODOSIN | SILODOSIN | 1 | Oral | 8 MG (8 MG,1 IN 1 D) | UNKNOWN | 0 | 8 | MG | QD | ||||||
| 126540332 | 12654033 | 9 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MG (10 MG,1 IN 1 D) | UNKNOWN | 0 | 10 | MG | FILM-COATED TABLET | QD | |||||
| 126540332 | 12654033 | 10 | SS | BISOPROLOL | BISOPROLOL | 1 | Oral | UNKNOWN | 0 | FILM-COATED TABLET | |||||||||
| 126540332 | 12654033 | 11 | SS | CYAMEMAZINE | CYAMEMAZINE | 1 | Oral | 25 MG (25 MG,1 IN 1 D) | UNKNOWN | 0 | 25 | MG | FILM-COATED TABLET | QD | |||||
| 126540332 | 12654033 | 12 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 75 MG (75 MG,1 IN 1 D) | UNKNOWN | 0 | 75 | MG | QD | ||||||
| 126540332 | 12654033 | 13 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | UNKNOWN | 0 | |||||||||||
| 126540332 | 12654033 | 14 | SS | PHENOBARBITAL. | PHENOBARBITAL | 1 | Oral | 150 MG (150 MG,1 IN 1 D) | UNKNOWN | 0 | 150 | MG | QD | ||||||
| 126540332 | 12654033 | 15 | SS | TIOTROPIUM | TIOTROPIUM | 1 | Respiratory (inhalation) | UNKNOWN | 0 | ||||||||||
| 126540332 | 12654033 | 16 | SS | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | Cutaneous | UNKNOWN | 0 | QD | |||||||||
| 126540332 | 12654033 | 17 | SS | FORMOTEROL | FORMOTEROL | 1 | Respiratory (inhalation) | UNKNOWN | 0 | ||||||||||
| 126540332 | 12654033 | 18 | SS | ALIMEMAZINE | TRIMEPRAZINE | 1 | Oral | 15 MG (5 MG,3 IN 1 D) | UNKNOWN | 0 | 15 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126540332 | 12654033 | 1 | Product used for unknown indication |
| 126540332 | 12654033 | 2 | Product used for unknown indication |
| 126540332 | 12654033 | 3 | Product used for unknown indication |
| 126540332 | 12654033 | 4 | Product used for unknown indication |
| 126540332 | 12654033 | 5 | Product used for unknown indication |
| 126540332 | 12654033 | 6 | Product used for unknown indication |
| 126540332 | 12654033 | 7 | Product used for unknown indication |
| 126540332 | 12654033 | 8 | Product used for unknown indication |
| 126540332 | 12654033 | 9 | Product used for unknown indication |
| 126540332 | 12654033 | 10 | Product used for unknown indication |
| 126540332 | 12654033 | 11 | Product used for unknown indication |
| 126540332 | 12654033 | 12 | Product used for unknown indication |
| 126540332 | 12654033 | 13 | Product used for unknown indication |
| 126540332 | 12654033 | 14 | Product used for unknown indication |
| 126540332 | 12654033 | 15 | Product used for unknown indication |
| 126540332 | 12654033 | 16 | Product used for unknown indication |
| 126540332 | 12654033 | 17 | Product used for unknown indication |
| 126540332 | 12654033 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126540332 | 12654033 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126540332 | 12654033 | Hyponatraemia | |
| 126540332 | 12654033 | Inappropriate antidiuretic hormone secretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126540332 | 12654033 | 1 | 2015 | 0 | ||
| 126540332 | 12654033 | 4 | 20160715 | 0 | ||
| 126540332 | 12654033 | 13 | 2015 | 0 |